An evaluation of the role of tumor load in cytoreductive nephrectomy.
暂无分享,去创建一个
R. Motzer | P. Russo | O. Akin | A. Hakimi | M. Voss | J. Coleman | E. Reznik | C. Duzgol | J. Marcon | R. Mano | A. Silagy | R. Dinatale | Kyle A. Blum | R. DiNatale
[1] R. Motzer,et al. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. , 2019, European urology oncology.
[2] Huadan Xue,et al. Can quantitative CT texture analysis be used to differentiate subtypes of renal cell carcinoma? , 2019, Clinical radiology.
[3] K. Bensalah,et al. Sunitinib Alone or after Nephrectomy in Metastatic Renal‐Cell Carcinoma , 2018, The New England journal of medicine.
[4] S. Bier,et al. Value of computed tomography texture analysis for prediction of perioperative complications during laparoscopic partial nephrectomy in patients with renal cell carcinoma , 2018, PloS one.
[5] M. Blute,et al. Metastatic Tumor Burden Does Not Predict Overall Survival Following Cytoreductive Nephrectomy for Renal Cell Carcinoma: a Novel 3-Dimensional Volumetric Analysis. , 2017, Urology.
[6] U. Neumann,et al. Fast and accurate liver volumetry prior to hepatectomy. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[7] J. Haanen,et al. Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma. , 2016, Urologic oncology.
[8] A. Graser,et al. Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm , 2014, European Radiology.
[9] T. Choueiri,et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. , 2013, The Lancet. Oncology.
[10] John M Buatti,et al. Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma. , 2012, American journal of surgery.
[11] B. Lane,et al. Association of percentage of tumour burden removed with debulking nephrectomy and progression‐free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor‐targeted therapy , 2010, BJU international.
[12] P. Pierorazio,et al. Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed , 2007, BJU international.
[13] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[14] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .